REALIZE ADJUSTABLE GASTRIC BAND

FDA Premarket Approval P070009 S003

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval for a line extension to the realize adjustable gastric bandthe device, as modified, will be marketed under the trade name realize adjustable gastricband curved (model bd3xv) and is indicated for weight reduction for morbidly obese patientsand is indicated for individuals with a body mass index (bmi) of at least 40 kg/m2, or a bmi ofat least 35 kg/m2 with one or more comorbid conditions. The band is indicated for use only inmorbidly obese adult patients who have failed more conservative weight-reduction alternatives,such as supervised diet, exercise and behavior modification programs.

DeviceREALIZE ADJUSTABLE GASTRIC BAND
Generic NameImplant, Intragastric For Morbid Obesity
ApplicantOBTECH MEDICAL GMBH
Date Received2008-04-18
Decision Date2008-10-15
PMAP070009
SupplementS003
Product CodeLTI 
Advisory CommitteeGastroenterology/Urology
Supplement TypeNormal 180 Day Track
Supplement ReasonChange Design/components/specifications/material
Expedited ReviewNo
Combination Product No
Applicant Address OBTECH MEDICAL GMBH landis And Gyr Strasse 1 zug CH-63-6300

Supplemental Filings

Supplement NumberDateSupplement Type
P070009Original Filing
S017 2016-06-21 Normal 180 Day Track No User Fee
S016 2016-04-21 Normal 180 Day Track No User Fee
S015 2015-03-09 30-day Notice
S014 2011-11-04 30-day Notice
S013 2011-02-08 Real-time Process
S012 2011-02-08 135 Review Track For 30-day Notice
S011 2011-01-18 Normal 180 Day Track
S010 2010-06-29 30-day Notice
S009 2010-05-07 Special (immediate Track)
S008 2010-06-07 Real-time Process
S007 2009-12-22 135 Review Track For 30-day Notice
S006 2009-09-08 30-day Notice
S005 2009-07-29 30-day Notice
S004 2008-09-29 135 Review Track For 30-day Notice
S003 2008-04-18 Normal 180 Day Track
S002 2008-03-13 30-day Notice
S001 2007-10-29 Normal 180 Day Track No User Fee

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.